|
Name |
Acoradiene
|
Molecular Formula | C15H24 | |
IUPAC Name* |
(1R,4S,5S)-1,8-dimethyl-4-prop-1-en-2-ylspiro[4.5]dec-8-ene
|
|
SMILES |
C[C@@H]1CC[C@H]([C@]12CCC(=CC2)C)C(=C)C
|
|
InChI |
InChI=1S/C15H24/c1-11(2)14-6-5-13(4)15(14)9-7-12(3)8-10-15/h7,13-14H,1,5-6,8-10H2,2-4H3/t13-,14+,15-/m1/s1
|
|
InChIKey |
DVBSKQAFCDJNSL-QLFBSQMISA-N
|
|
Synonyms |
Acoradiene; 24048-44-0; (1R,4S,5S)-1,8-dimethyl-4-prop-1-en-2-ylspiro[4.5]dec-8-ene; DTXSID60946894; 1,8-Dimethyl-4-(1-methylethenyl)-spiro(4,5)dec-7-ene (1R-(1alpha,4beta,5beta))-; Spiro(4,5)dec-7-ene, 1,8-dimethyl-4-(1-methylethenyl)-, (1R-(1alpha,4beta,5beta))-; 1,8-DIMETHYL-4-(PROP-1-EN-2-YL)SPIRO[4.5]DEC-7-ENE
|
|
CAS | 24048-44-0 | |
PubChem CID | 90351 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 204.35 | ALogp: | 5.1 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 15 | QED Weighted: | 0.518 |
Caco-2 Permeability: | -4.441 | MDCK Permeability: | 0.00001580 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.975 |
30% Bioavailability (F30%): | 0.951 |
Blood-Brain-Barrier Penetration (BBB): | 0.106 | Plasma Protein Binding (PPB): | 95.19% |
Volume Distribution (VD): | 4.02 | Fu: | 4.57% |
CYP1A2-inhibitor: | 0.847 | CYP1A2-substrate: | 0.208 |
CYP2C19-inhibitor: | 0.459 | CYP2C19-substrate: | 0.865 |
CYP2C9-inhibitor: | 0.21 | CYP2C9-substrate: | 0.419 |
CYP2D6-inhibitor: | 0.061 | CYP2D6-substrate: | 0.493 |
CYP3A4-inhibitor: | 0.752 | CYP3A4-substrate: | 0.268 |
Clearance (CL): | 16.941 | Half-life (T1/2): | 0.088 |
hERG Blockers: | 0.06 | Human Hepatotoxicity (H-HT): | 0.432 |
Drug-inuced Liver Injury (DILI): | 0.297 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.101 | Maximum Recommended Daily Dose: | 0.244 |
Skin Sensitization: | 0.808 | Carcinogencity: | 0.75 |
Eye Corrosion: | 0.934 | Eye Irritation: | 0.931 |
Respiratory Toxicity: | 0.251 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002392 | 1.000 | D04SFH | 0.253 | ||||
ENC003255 | 0.519 | D0F1UL | 0.250 | ||||
ENC002990 | 0.519 | D0B4RU | 0.250 | ||||
ENC001813 | 0.464 | D07BSQ | 0.250 | ||||
ENC001832 | 0.414 | D04GJN | 0.225 | ||||
ENC005089 | 0.410 | D0I2SD | 0.225 | ||||
ENC001831 | 0.390 | D02CJX | 0.221 | ||||
ENC001829 | 0.390 | D02CNR | 0.216 | ||||
ENC003109 | 0.390 | D0A2AJ | 0.213 | ||||
ENC000555 | 0.388 | D0V2JK | 0.211 |